Syneos Health, Inc.

NasdaqGS:SYNH 주식 보고서

시가총액: US$4.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Syneos Health 관리

관리 기준 확인 1/4

Syneos Health's CEO는 Michelle Keefe, Apr2022 에 임명되었습니다 의 임기는 1.42 년입니다. 총 연간 보상은 $ 8.89M, 9.7% 로 구성됩니다. 9.7% 급여 및 90.3% 보너스(회사 주식 및 옵션 포함). 는 $ 1.53M 가치에 해당하는 회사 주식의 0.034% 직접 소유합니다. 1.53M. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 2.3 년입니다.

주요 정보

Michelle Keefe

최고 경영자

US$8.9m

총 보상

CEO 급여 비율9.7%
CEO 임기1.4yrs
CEO 소유권0.03%
경영진 평균 재임 기간2.7yrs
이사회 평균 재임 기간2.3yrs

최근 관리 업데이트

Recent updates

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 29
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Mar 10
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Feb 20
Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Dec 20
Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Nov 28
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Nov 01
Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Syneos, Datavant expand partnership on data analytics for clinical trials

Oct 11

Syneos Health falls 13% after update on outlook

Sep 13

When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Sep 08
When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Aug 22
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Syneos Health Q2 2022 Earnings Preview

Aug 01

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Jul 19
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Syneos: Upside Could Be Priced In, Valuations Unsupportive

Jul 15

Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Jun 18
Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Jun 03
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

May 19
We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Apr 08
Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors

Mar 27

Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 05
Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Feb 18
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

Feb 03
Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Jan 04
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022

Dec 03

Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Dec 03
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

CEO 보상 분석

Michelle Keefe 의 보수는 Syneos Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2023n/an/a

US$71m

Mar 31 2023n/an/a

US$148m

Dec 31 2022US$9mUS$862k

US$266m

Sep 30 2022n/an/a

US$287m

Jun 30 2022n/an/a

US$278m

Mar 31 2022n/an/a

US$242m

Dec 31 2021US$2mUS$567k

US$235m

Sep 30 2021n/an/a

US$251m

Jun 30 2021n/an/a

US$236m

Mar 31 2021n/an/a

US$198m

Dec 31 2020US$2mUS$522k

US$193m

Sep 30 2020n/an/a

US$192m

Jun 30 2020n/an/a

US$187m

Mar 31 2020n/an/a

US$195m

Dec 31 2019US$2mUS$550k

US$131m

보상 대 시장: Michelle 의 총 보상 ($USD 8.89M )은 US 시장( $USD 6.80M ).

보상과 수익: Michelle 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.


CEO

Michelle Keefe (56 yo)

1.4yrs

테뉴어

US$8,889,996

보상

Ms. Michelle Keefe serves as Chief Executive Officer at Syneos Health, Inc since April 29, 2022 and serves as its Director since 2022. She served as President of Medical Affairs and Commercial Solutions fo...


리더십 팀

이름위치테뉴어보상소유권
Michelle Keefe
CEO & Director1.4yrsUS$8.89m0.034%
$ 1.5m
Michael Brooks
Chief Operating Officer1.4yrsUS$6.04m0.018%
$ 810.0k
Jonathan Olefson
General Counsel & Corporate Secretary4.8yrsUS$3.52m0.014%
$ 617.4k
Christian Tucat
Chief Business Officer5yrsUS$2.62m0.011%
$ 502.0k
Jason Meggs
Consultantless than a yearUS$3.19m0.039%
$ 1.8m
Michael Bonello
Chief Financial Officerless than a year데이터 없음데이터 없음
Donna Kralowetz
Senior VP of Finance & Chief Accounting Officer2.7yrs데이터 없음0.0029%
$ 130.6k
Baba Shetty
President of Technology & Data Solutions1.4yrs데이터 없음데이터 없음
Judith Ng-Cashin
Chief Scientific Officer7.5yrs데이터 없음데이터 없음
Larry Pickett
Chief Information & Digital Officer2.8yrs데이터 없음데이터 없음
Ronnie Speight
Senior Vice President of Investor Relationsno data데이터 없음데이터 없음
Kristen Spensieri
Global Head of Corporate Communications & Marketing6.1yrs데이터 없음데이터 없음

2.7yrs

평균 재임 기간

52.5yo

평균 연령

경험이 풍부한 관리: SYNH 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Michelle Keefe
CEO & Director1.7yrsUS$8.89m0.034%
$ 1.5m
Kenneth Meyers
Independent Director6.9yrsUS$370.77k0.019%
$ 865.7k
William Klitgaard
Independent Directorless than a yearUS$182.56k0%
$ 0
Matthew Monaghan
Independent Director6.9yrsUS$322.77k0.019%
$ 850.1k
Alfonso Zulueta
Independent Director1.7yrsUS$351.39k0.0034%
$ 150.2k
John Dineen
Independent Chairman4.8yrsUS$483.27k0.022%
$ 972.7k
David Wilkes
Independent Director2.3yrsUS$308.52k0.0048%
$ 213.5k
Bernadette Connaughton
Independent Director3.8yrsUS$307.77k0.0096%
$ 426.2k
Barbara Bodem
Independent Director1.7yrsUS$369.53k0.0034%
$ 151.6k

2.3yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: SYNH 의 이사회경험(평균 재직 기간 2.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.